US OptionsDetailed Quotes

CTXR241220P2500

Watchlist

0.00
0.000.00%

15min DelayTrading Nov 18 09:30 ET

0.00High0.00Low

Citius Pharmaceuticals Stock Discussion

萬軍無兵策天鳳

Nov 16 00:06

$Citius Pharmaceuticals (CTXR.US)$ 增发时新闻里是这么写的“Citius Pharma's ability to regain compliance with and continue to meet Nasdaq's continued listing standards; our ability to commercialize LYMPHIR and any of our other product candidates that may be approved by the FDA”

Stock_Drift

Nov 15 12:55

$Citius Pharmaceuticals (CTXR.US)$

Buzz killington

Nov 14 09:50

$Citius Pharmaceuticals (CTXR.US)$ lmao what a scam piece of shit they go and have the scam institutions put out a bunch of high ratings just to crash it on everyone buying in good thing I seen the manipulation in the book and got out with only a 88 dollar loss could have been thousands

Teddy123

Nov 14 05:50

Has until 3 Dec to go to 1

$Citius Pharmaceuticals (CTXR.US)$
0
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;

As previously disclosed, on September 12, 2023, Citius Pharmaceuticals, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.001 per share, for the prior 30 cons...

Teddy123

Nov 12 15:02

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer

$Citius Pharmaceuticals (CTXR.US)$
CRANFORD, N.J., Nov. 11, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), today announced promising preliminary results from an ongoing investigator-initia...

Teddy123

Nov 12 06:29

Strive for $1!

$Citius Pharmaceuticals (CTXR.US)$

Teddy123

Nov 11 08:20

Citius Pharmaceuticals and Citius Oncology Report Prelim Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab and LYMPHIR

$Citius Pharmaceuticals (CTXR.US)$
Citius Pharmaceuticals (NASDAQ:CTXR), Inc. (Nasdaq: CTXR) and Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), today announced promising preliminary results from an ongoing investigator-initiated Phase I clinical trial evaluating the safety and efficacy of a combined regimen of pembrolizumab and LYMPHIR™ (denil...

MangoXoXo

Nov 11 08:03

$Citius Pharmaceuticals (CTXR.US)$ 😎

Trytosaveabit

Nov 11 07:55

Update

$Citius Pharmaceuticals (CTXR.US)$ Reuters· 7 mins ago
Citius Pharmaceuticals: Chemotherapy-Free Immunomodulatory Regimen Well-Tolerated With No Serious Immune-Related Adverse Events

Stock_Drift

Nov 11 07:06

$Citius Pharmaceuticals (CTXR.US)$

No comment yet